MoonLake Immunotherapeutics Company
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company crating novel therapies, and unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients.
Founded Date:
2021-03-01
Employee Number:
101-250
Headquarters:
Zug, Zug, Switzerland, Europe
Industry:
Drug Discovery & Development
Super Industry:
Biopharma & Life Science Tools
Phone Number:
+41 415108022
Investors:
Biotechnology Value Fund, Cormorant Asset Management, Darmstadt, Hercules Capital, Merck KGaA, RTW Investments
Ipo Status:
public
Stock Symbol:
MLTX
City:
Zug
Region:
Zug
Country:
Switzerland
Founders:
Jorge Silva